Terms: = Thyroid cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
571 results:
1. Decabromodiphenyl ether exposure reduces dabrafenib sensitivity of papillary thyroid carcinoma harboring BRAF
Wang X; Cui X; Wang Y; Wang Q; Sun F; Liu Z
Toxicology; 2024 May; 504():153807. PubMed ID: 38641160
[TBL] [Abstract] [Full Text] [Related]
2. thyroid dysfunction after immune checkpoint inhibitors in a single-centre UK pan-cancer cohort: A retrospective study.
Kennedy OJ; Ali N; Lee R; Monaghan P; Adam S; Cooksley T; Lorigan P
Eur J Cancer; 2024 May; 202():113949. PubMed ID: 38432099
[TBL] [Abstract] [Full Text] [Related]
3. Lazertinib as a frontline treatment in patients with egfr-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201.
Chul Cho B; Han JY; Hyeong Lee K; Lee YG; Kim DW; Joo Min Y; Kim SW; Kyung Cho E; Kim JH; Lee GW; Sook Lee S; Lee N; Young Wang J; Park H; Ahn MJ
Lung Cancer; 2024 Apr; 190():107509. PubMed ID: 38432025
[TBL] [Abstract] [Full Text] [Related]
4.
Li F; Wu Y; Shi Y; Liu X; Xie Y; Liu S
Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):462-473. PubMed ID: 38379418
[TBL] [Abstract] [Full Text] [Related]
5. Feasibility of whole-exome sequencing in fine-needle aspiration specimens of papillary thyroid microcarcinoma for the identification of novel gene mutations.
Ma L; Gao L; Hu Y; Li X; Liu C; Ji J; Shi X; Pan A; An Y; Luo N; Xia Y; Jiang Y
Clin Genet; 2024 May; 105(5):567-572. PubMed ID: 38326996
[TBL] [Abstract] [Full Text] [Related]
6. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
Fukuda N; Toda K; Suto H; Oki R; Wang X; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
Endocr J; 2024 Apr; 71(4):363-371. PubMed ID: 38296547
[TBL] [Abstract] [Full Text] [Related]
7. CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating egfr and activating the PI3K/Akt signaling.
Wang Z; Zhou T; Chen X; Zhu X; Liao B; Liu J; Li S; Tan T; Liu Y
Neoplasma; 2023 Dec; 70(6):761-776. PubMed ID: 38247332
[TBL] [Abstract] [Full Text] [Related]
8. Lung adenocarcinoma metastasis within a pituitary neuroendocrine tumor: a case report with review of literature.
Suzuki K; Tahara S; Hattori Y; Teramoto S; Ishisaka E; Inomoto C; Osamura RY; Morita A; Murai Y
Endocr J; 2024 Mar; 71(3):295-303. PubMed ID: 38171721
[TBL] [Abstract] [Full Text] [Related]
9. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
10. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve thyroid cancer with Aggressive Behavior.
Revilla G; Al Qtaish N; Caruana P; Sainz-Ramos M; Lopez-Mendez T; Rodriguez F; Paez-Espinosa V; Li C; Vallverdú NF; Edwards M; Moral A; Pérez JI; Escolà-Gil JC; Pedraz JL; Gallego I; Corcoy R; Céspedes MV; Puras G; Mato E
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002329
[TBL] [Abstract] [Full Text] [Related]
11. Associations between BMI in youth and site-specific cancer in men-A cohort study with register linkage.
Onerup A; Mehlig K; Af Geijerstam A; Ekblom-Bak E; Kuhn HG; Lissner L; Rosengren A; Börjesson M; Åberg M
Obesity (Silver Spring); 2024 Feb; 32(2):376-389. PubMed ID: 37927128
[TBL] [Abstract] [Full Text] [Related]
12. NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of egfr signaling.
Qiao L; Dong C; Jia W; Ma B
Cell Signal; 2023 Dec; 112():110922. PubMed ID: 37827343
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer.
Chen D; Li L; Wang M; Hu X; Jiang J; Li W; Yang L; Fan M; Shi Y; Lv F; Liu Y
Front Immunol; 2023; 14():1086479. PubMed ID: 37795095
[TBL] [Abstract] [Full Text] [Related]
14. Pyrotinib-based therapeutic approaches for HER2-positive breast cancer: the time is now.
Qi X; Shi Q; Xuhong J; Zhang Y; Jiang J
Breast Cancer Res; 2023 Oct; 25(1):113. PubMed ID: 37789330
[TBL] [Abstract] [Full Text] [Related]
15. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
16. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
[TBL] [Abstract] [Full Text] [Related]
17. Profiling extracellular vesicle surface proteins with 10 µL peripheral plasma within 4 h.
He J; Li H; Mai J; Ke Y; Zhai C; Li JJ; Jiang L; Shen G; Ding X
J Extracell Vesicles; 2023 Sep; 12(9):e12364. PubMed ID: 37654045
[TBL] [Abstract] [Full Text] [Related]
18. A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell Fusion.
Han D; He XY; Huang Y; Gao M; Guo T; Ren XH; Liao XR; Chen XS; Pang X; Cheng SX
Adv Sci (Weinh); 2023 Oct; 10(29):e2303309. PubMed ID: 37590231
[TBL] [Abstract] [Full Text] [Related]
19. Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics.
Rodrigues L; Watson J; Feng Y; Lewis B; Harvey G; Post G; Megquier K; White ME; Lambert L; Miller A; Lopes C; Zhao S
Sci Rep; 2023 Jul; 13(1):10935. PubMed ID: 37414794
[TBL] [Abstract] [Full Text] [Related]
20. Lazertinib versus Gefitinib as First-Line Treatment for egfr-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.
Lee KH; Cho BC; Ahn MJ; Lee YG; Lee Y; Lee JS; Kim JH; Min YJ; Lee GW; Lee SS; Lee KH; Ko YH; Shim BY; Kim SW; Shin SW; Choi JH; Kim DW; Cho EK; Park KU; Kim JS; Chun SH; Wang J; Choi S; Kang JH
Cancer Res Treat; 2024 Jan; 56(1):48-60. PubMed ID: 37402411
[TBL] [Abstract] [Full Text] [Related]
[Next]
